Regulation of thrombospondin-1 expression in alternatively activated macrophages and adipocytes: Role of cellular cross talk and omega-3 fatty acids

Journal of Nutritional Biochemistry

Volumn 24, Issue 9, 2013, Pages 1571-1579

  Finlin, Brian S ^a   Zhu, Beibei ^a   Starnes, Catherine P ^b   McGehee, Robert E ^c   Peterson, Charlotte A ^b   Kern, Philip A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adipocyte; Docosahexaenoic acid; IL 10; Macrophage; Thrombospondin 1

Indexed keywords

DOCOSAHEXAENOIC ACID; INTERLEUKIN 10; MESSENGER RNA; OMEGA 3 ACID ETHYL ESTER; OMEGA 3 FATTY ACID; SMALL INTERFERING RNA; THROMBOSPONDIN 1;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; COCULTURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME INHIBITION; FIBROBLAST; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MACROPHAGE; MESANGIUM CELL; OBESITY; PROTEIN EXPRESSION;

EID: 84881542196     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.01.007     Document Type: Article

References (53)

1. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 2011, 18:139-143.
2. Di Gregorio G.B., Yao-Borengasser A., Rasouli N., Varma V., Lu T., Miles L.M., et al. Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 2005, 54:2305-2313.
3. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112:1796-1808.
4. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003, 112:1821-1830.
5. Sun K., Kusminski C.M., Scherer P.E. Adipose tissue remodeling and obesity. J Clin Invest 2011, 121:2094-2101.
6. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010, 72:219-246.
7. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004, 25:677-686.
8. Stout R.D., Suttles J. Functional plasticity of macrophages: reversible adaptation to changing microenvironments. J Leukoc Biol 2004, 76:509-513.
9. Wentworth J.M., Naselli G., Brown W.A., Doyle L., Phipson B., Smyth G.K., et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010, 59:1648-1656.
10. Spencer M., Yao-Borengasser A., Unal R., Rasouli N., Gurley C.M., Zhu B., et al. Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation. Am J Physiol Endocrinol Metab 2010, 299:E1016-E1027.
11. Zeyda M., Farmer D., Todoric J., Aszmann O., Speiser M., Gyori G., et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (Lond) 2007, 31:1420-1428.
12. Bourlier V., Zakaroff-Girard A., Miranville A., De Barros S., Maumus M., Sengenes C., et al. Remodeling phenotype of human subcutaneous adipose tissue macrophages. Circulation 2008, 117:806-815.
13. Khan T., Muise E.S., Iyengar P., Wang Z.V., Chandalia M., Abate N., et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 2009, 29:1575-1591.
14. Halberg N., Khan T., Trujillo M.E., Wernstedt-Asterholm I., Attie A.D., Sherwani S., et al. Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue. Mol Cell Biol 2009, 29:4467-4483.
15. Pasarica M., Sereda O.R., Redman L.M., Albarado D.C., Hymel D.T., Roan L.E., et al. Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response. Diabetes 2009, 58:718-725.
16. Varma V., Yao-Borengasser A., Bodles A.M., Rasouli N., Phanavanh B., Nolen G.T., et al. Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. Diabetes 2008, 57:432-439.
17. Schultz-Cherry S., Murphy-Ullrich J.E. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 1993, 122:923-932.
18. Sweetwyne M.T., Pallero M.A., Lu A., Van Duyn Graham L., Murphy-Ullrich J.E. The calreticulin-binding sequence of thrombospondin 1 regulates collagen expression and organization during tissue remodeling. Am J Pathol 2010, 177:1710-1724.
19. Voros G., Maquoi E., Demeulemeester D., Clerx N., Collen D., Lijnen H.R. Modulation of angiogenesis during adipose tissue development in murine models of obesity. Endocrinology 2005, 146:4545-4554.
20. Li Y., Tong X., Rumala C., Clemons K., Wang S. Thrombospondin1 deficiency reduces obesity-associated inflammation and improves insulin sensitivity in a diet-induced obese mouse model. PLoS One 2011, 6:e26656.
21. Bornstein P. Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal 2009, 3:189-200.
22. Sweetwyne M.T., Murphy-Ullrich J.E. Thrombospondin1 in tissue repair and fibrosis: TGF-beta-dependent and independent mechanisms. Matrix Biol 2012, 31:178-186.
23. Rutkowski J.M., Davis K.E., Scherer P.E. Mechanisms of obesity and related pathologies: the macro- and microcirculation of adipose tissue. FEBS J 2009, 276:5738-5746.
24. Priante G., Musacchio E., Valvason C., Baggio B. EPA and DHA suppress AngII- and arachidonic acid-induced expression of profibrotic genes in human mesangial cells. J Nephrol 2009, 22:137-143.
25. Chen J., Shearer G.C., Chen Q., Healy C.L., Beyer A.J., Nareddy V.B., et al. Omega-3 fatty acids prevent pressure overload-induced cardiac fibrosis through activation of cyclic GMP/protein kinase G signaling in cardiac fibroblasts. Circulation 2011, 123:584-593.
26. Oh D.Y., Talukdar S., Bae E.J., Imamura T., Morinaga H., Fan W., et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142:687-698.
27. Storlien L.H., Kraegen E.W., Chisholm D.J., Ford G.L., Bruce D.G., Pascoe W.S. Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987, 237:885-888.
28. Finlin B.S., Varma V., Nolen G.T., Dube J., Starnes C.P., Rasouli N., et al. DHA reduces the atrophy-associated Fn14 protein in differentiated myotubes during coculture with macrophages. J Nutr Biochem 2012, 23:885-891.
29. Igarashi A., Okochi H., Bradham D.M., Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 1993, 4:637-645.
30. Jung H., Kim H.H., Lee D.H., Hwang Y.S., Yang H.C., Park J.C. Transforming growth factor-beta 1 in adipose derived stem cells conditioned medium is a dominant paracrine mediator determines hyaluronic acid and collagen expression profile. Cytotechnology 2011, 63:57-66.
31. Doyen V., Rubio M., Braun D., Nakajima T., Abe J., Saito H., et al. Thrombospondin 1 is an autocrine negative regulator of human dendritic cell activation. J Exp Med 2003, 198:1277-1283.
32. Torres-Aguilar H., Aguilar-Ruiz S.R., Gonzalez-Perez G., Munguia R., Bajana S., Meraz-Rios M.A., et al. Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells. J Immunol 2010, 184:1765-1775.
33. Spencer M., Unal R., Zhu B., Rasouli N., McGehee R.E., Peterson C.A., et al. Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance. J Clin Endocrinol Metab 2011, 96:E1990-E1998.
34. Pasarica M., Rood J., Ravussin E., Schwarz J.M., Smith S.R., Redman L.M. Reduced oxygenation in human obese adipose tissue is associated with impaired insulin suppression of lipolysis. J Clin Endocrinol Metab 2010, 95:4052-4055.
35. Pasarica M., Gowronska-Kozak B., Burk D., Remedios I., Hymel D., Gimble J., et al. Adipose tissue collagen VI in obesity. J Clin Endocrinol Metab 2009, 94:5155-5162.
36. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
37. Suganami T., Tanimoto-Koyama K., Nishida J., Itoh M., Yuan X., Mizuarai S., et al. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007, 27:84-91.
38. Kawakami T., Tokunaga T., Hatanaka H., Tsuchida T., Tomii Y., Osada H., et al. Interleukin 10 expression is correlated with thrombospondin expression and decreased vascular involvement in colon cancer. Int J Oncol 2001, 18:487-491.
39. Petursdottir D.H., Olafsdottir I., Hardardottir I. Dietary fish oil increases tumor necrosis factor secretion but decreases interleukin-10 secretion by murine peritoneal macrophages. J Nutr 2002, 132:3740-3743.
40. Wong S.W., Kwon M.J., Choi A.M., Kim H.P., Nakahira K., Hwang D.H. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009, 284:27384-27392.
41. Singer P., Shapiro H., Theilla M., Anbar R., Singer J., Cohen J. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 2008, 34:1580-1592.
42. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010, 10:170-181.
43. Shi H., Kokoeva M.V., Inouye K., Tzameli I., Yin H., Flier J.S. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015-3025.
44. Chang Z.L. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res 2010, 59:791-808.
45. Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants?. J Leukoc Biol 2010, 87:989-999.
46. He R.L., Zhou J., Hanson C.Z., Chen J., Cheng N., Ye R.D. Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2. Blood 2009, 113:429-437.
47. Norseen J., Hosooka T., Hammarstedt A., Yore M.M., Kant S., Aryal P., et al. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol 2012, 32:2010-2019.
48. Serhan C.N., Petasis N.A. Resolvins and protectins in inflammation resolution. Chem Rev 2011, 111:5922-5943.
49. Calder P.C. Mechanisms of action of (n-3) fatty acids. J Nutr 2012, 142:592S-599S.
50. Dewell A., Marvasti F.F., Harris W.S., Tsao P., Gardner C.D. Low- and high-dose plant and marine (n-3) fatty acids do not affect plasma inflammatory markers in adults with metabolic syndrome. J Nutr 2011, 141:2166-2171.
51. Tierney A.C., McMonagle J., Shaw D.I., Gulseth H.L., Helal O., Saris W.H., et al. Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome-LIPGENE: a European randomized dietary intervention study. Int J Obes (Lond) 2011, 35:800-809.
52. Griffin M.D., Sanders T.A., Davies I.G., Morgan L.M., Millward D.J., Lewis F., et al. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr 2006, 84:1290-1298.
53. Kabir M., Skurnik G., Naour N., Pechtner V., Meugnier E., Rome S., et al. Treatment for 2 mo with n 3 polyunsaturated fatty acids reduces adiposity and some atherogenic factors but does not improve insulin sensitivity in women with type 2 diabetes: a randomized controlled study. Am J Clin Nutr 2007, 86:1670-1679.